Allogene Therapeutics
ALLO
#7442
Rank
โ‚น26.74 B
Marketcap
โ‚น123.09
Share price
4.35%
Change (1 day)
-63.59%
Change (1 year)

Allogene Therapeutics (ALLO) - Cash on Hand

Cash on Hand as of December 2024 : โ‚น25.00 Billion

According to Allogene Therapeutics 's latest financial reports the company has โ‚น25.00 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Allogene Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น25.09 B-32.83%
2023-12-31โ‚น37.35 B-12.74%
2022-12-31โ‚น42.80 B25.77%
2021-12-31โ‚น34.03 B-43.78%
2020-12-31โ‚น60.54 B60.04%
2019-12-31โ‚น37.83 B17.78%
2018-12-31โ‚น32.12 B
2017-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น21.87 B-12.49%๐Ÿ‡บ๐Ÿ‡ธ USA